Celecoxib Impurity 15 | CAS 1576-43-8 - Request Quote
Celecoxib Impurity 15
| SZ CAT No: | SZ-C005025 |
| CAS No | 1576-43-8 |
| Mol.F. | C6H7NO3S |
| Mol.Wt. | 173.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Celecoxib Impurity 15 is chemically 4-Hydroxy benzene sulfonamide. Celecoxib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Celecoxib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Celecoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1576-43-8
Purchase 1576-43-8
Order 1576-43-8
Enquire 1576-43-8
price of 1576-43-8
1576-43-8 Supplier
1576-43-8 Manufacturer
1576-43-8 Exporter
buy high quality Celecoxib Impurity 15
Purchase Celecoxib Impurity 15
Celecoxib Impurity 15 suppliers
Celecoxib Impurity 15 manufacturers
Celecoxib Impurity 15 price
Order Celecoxib Impurity 15
Enquire Celecoxib Impurity 15
Celecoxib Impurity 15 cost
Celecoxib Impurity 15 Supplier
Celecoxib Impurity 15 Distributor
Celecoxib Impurity 15 for Method Validation
Celecoxib Reference Standard
Celecoxib Impurity 15 for ANDA Filing
Celecoxib Impurity 15 for Forced Degradation Studies
Celecoxib Impurity 15 Identification Standards
Celecoxib Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.